Colgate-Palmolive Company (NYSE:CL) posted better-than-expected fourth-quarter earnings on Friday.
The company reported fourth-quarter adjusted earnings per share of 95 cents, beating the analyst consensus estimate of 91 cents. Quarterly sales of $5.230 billion, beating the Street view of $5.118 billion.
“Net sales and organic sales grew in every category during the quarter, led by strength in oral care and pet nutrition, excluding private label,” said CEO Noel Wallace.
Colgate-Palmolive forecasts fiscal 2026 sales of $20.79 billion to $21.61 billion, compared with analysts’ estimate of $20.98 billion.
Colgate-Palmolive shares gained 2% to trade at $92.11 on Monday.
These analysts made changes to their price targets on Colgate-Palmolive following earnings announcement.
- Deutsche Bank analyst Steve Powers maintained Colgate-Palmolive with …